Syros Pharmaceuticals Inc SYRS:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 09/30/22 EDT
6.35quote price arrow down-0.09 (-1.40%)
Volume
3,714
Close
6.44quote price arrow up+0.60 (+10.27%)
Volume
164,891
52 week range
5.25 - 48.00
Loading...
  • Open5.84
  • Day High6.51
  • Day Low5.84
  • Prev Close5.84
  • 52 Week High48.00
  • 52 Week High Date10/13/21
  • 52 Week Low5.25
  • 52 Week Low Date09/19/22

Key Stats

  • Market Cap40.57M
  • Shares Out6.30M
  • 10 Day Average Volume0.59M
  • Dividend-
  • Dividend Yield-
  • Beta1.68
  • YTD % Change-80.25

KEY STATS

  • Open5.84
  • Day High6.51
  • Day Low5.84
  • Prev Close5.84
  • 52 Week High48.00
  • 52 Week High Date10/13/21
  • 52 Week Low5.25
  • 52 Week Low Date09/19/22
  • Market Cap40.57M
  • Shares Out6.30M
  • 10 Day Average Volume0.59M
  • Dividend-
  • Dividend Yield-
  • Beta1.68
  • YTD % Change-80.25

RATIOS/PROFITABILITY

  • EPS (TTM)-17.31
  • P/E (TTM)-0.37
  • Fwd P/E (NTM)-0.86
  • EBITDA (TTM)-109.745M
  • ROE (TTM)-135.99%
  • Revenue (TTM)25.24M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-433.67%
  • Debt To Equity (MRQ)131.69%

EVENTS

  • Earnings Date11/03/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Syros Pharmaceuticals Inc

 

Content From Our Affiliates

Profile

MORE
Syros Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on redefending the power of small molecules to control the expression of genes. The Company is engaged in developing treatments for cancer and diseases resulting from mutations of a single gene, also known as monogenic diseases, and building a clinical-stage pipeline of gene control medicine. The Company's lead product candidates include Tamibarotene, SY-2101 and SY-5609. Its Tamibarotene, is a...
Peter Wirth J.D.
Independent Chairman of the Board
Nancy Simonian M.D.
President, Chief Executive Officer, Director
Jason Haas
Chief Financial Officer
Address
35 Cambridge Park Drive
Cambridge, MA
02140
United States

Top Peers

SYMBOLLASTCHG%CHG
HARP
Harpoon Therapeutics Inc
0.9701+0.115+13.45%
ORGS
Orgenesis Inc
1.42+0.04+2.90%
CDTX
Cidara Therapeutics Inc
0.628-0.0221-3.3995%
ANGN
Angion Biomedica Corp
0.92+0.0197+2.19%
OBSV
Obseva SA
0.1421-0.0017-1.1822%